Related Experiment Video
Updated: Jun 19, 2026
05:49
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Common infectious agents prevalence in antiphospholipid syndrome
H Zinger1, Y Sherer, G Goddard
1Department of Medicine B and Center of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
Lupus
|November 3, 2009
Summary
Antiphospholipid syndrome (APS) is linked to infections. This study found higher IgM antibodies to toxoplasma and rubella in APS patients, suggesting these infections may play a role in APS development or symptoms.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications.
- Infections are known triggers or exacerbating factors for autoimmune diseases, including APS.
- The specific role of infections in the pathogenesis of APS requires further elucidation.
Purpose of the Study:
- To investigate the association between specific infections and antiphospholipid syndrome (APS).
- To screen APS patients for antibodies against various infectious agents.
- To explore potential links between infections and the development or manifestation of APS.
Main Methods:
- Screening of 98 patients diagnosed with antiphospholipid syndrome.
- Detection of IgM antibodies targeting several infectious agents.
- Statistical analysis to determine the prevalence of specific antibodies in APS patients.
Main Results:
- A significantly higher prevalence of IgM antibodies against Toxoplasma and Rubella was observed in patients with APS.
- This finding suggests a potential association between Toxoplasma and Rubella infections and APS.
- The study highlights a novel link between specific infections and this autoimmune condition.
Conclusions:
- Toxoplasma and Rubella infections may be associated with the pathogenesis of antiphospholipid syndrome.
- Alternatively, these infections might be linked to the clinical manifestations of APS.
- Further research is warranted to confirm the causal relationship and clinical implications.
More Related Videos
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...